Further studies revealed that DPP4 acts as a binding protein for adenosine deaminase (ADA) and serves as a T cell activation marker, transmitting co-stimulatory signals upon ADA stimulation
Q1 2025: Eli Lilly acquires Synthekine for $1.2 billion to expand GLP-1 and metabolic disease pipeline Eli Lilly announced the acquisition of Synthekine, a biotech specializing in cytokine therapeutics, to enhance its pipeline of GLP-1 and related metabolic disease treatments
Stimulates Collagen and Elastin Synthesis: GHK-Cu upregulates genes associated with collagen, elastin, and glycosaminoglycan production, improving skin firmness and extracellular matrix integrity 3
Introduction of Generics and Oral Formulations: Market accessibility has improved through the approval of the first generic liraglutide (Victoza) earlier this year and generic exenatide last month
Severe zinc deficiency is also associated with acrodermatitis enteropathica, a rare autosomal recessive genetic disorder (252)
Contact us today to start your journey towards a healthier, happier